Andlauer Healthcare Group Inc.
AND.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$2 | CA$2 | CA$2 | CA$2 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$2 | CA$2 | CA$2 | CA$2 |
| Revenue | CA$1 | CA$1 | CA$1 | CA$0 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| EBITDA | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 25.6% | 25.8% | 27% | 35.8% |
| Net Income | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| % Growth | 1.9% | -13.4% | -20.4% | – |
| Operating Cash Flow | CA$0 | CA$0 | CA$0 | CA$0 |
| Capital Expenditures | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Free Cash Flow | CA$0 | CA$0 | CA$0 | CA$0 |